Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Author(s): Gilbert John A
Issue: Sep/Oct 2009 - Veterinary Compounding
View All Articles in Issue
Page(s): 400-403
Download in electronic PDF format for $65
Abstract: The practice of pharmaceutical compounding may involve the dispensing of controlled substances, a subset of prescription drug products. In such cases, the Drug Enforcement Administration has authority to regulate and enforce pharmacy compounding in the U.S. through the Controlled Substances Act and Drug Enforcement Administration regulations, although the Drug Enforcement Administration expressly acknowledges that the agency does not establish medical standards or guidelines on the treatment of pain. There is a need to balance the interests of law enforcement in reducing the potential for prescription drug abuse without adversely affecting the need to ensure appropriate availability and access to pain medicine. Compounding pharmacies provide an important service to practitioners and their patients suffering from chronic pain and debilitating illness. Without access to pain medicine, a patient’s needs would go unmet, resulting in unnecessary pain and suffering.
Related Keywords: John A. Gilbert, Jr., Esq, prescription drug abuse, controlled substances, U.S. Drug Enforcement Administration, DEA, law enforcement, Model Guidelines, pain medication, medical practice standards, online pharmacy, internet